Osteopore Ltd has released a press release.
OSX Successfully transitions to EU Medical Device Regulation
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Osteopore
- Reinstatement of Security Class to Quotation
- Security Class Suspension from Quotation
- Non-Renounceable Entitlement Offer - Results
- OSX Strengthens Presence in the Eastern Region of the USA
- OSX Completes Acquisition to Accelerate Revenue Growth
Later from Osteopore
- Activities Update Qtr Ending March 2023 and Appendix 4C
- Largest South African Medical Insurer provides cover for OSX
- Strategic Partnership for Clinical R&D in China worth $4M
- Osteopore strengthens Board & Management by key appointments
- OSX receives A$10m commitment for commercialisation in China
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore